Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 16Male Urogenital Diseases 3Prostatic Intraepithelial Neoplasia 2Uremia 1Prostatic Hyperplasia 1Neoplasms 1Neoplasm Metastasis 1Disease Progression 1Colorectal Cancer Metastatic 1Carcinoma, Transitional Cell 1

Interventions

Dutasteride 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Transurethral Resection of Prostate 2Therapeutics 2Radiotherapy 2Prostatectomy 2Blood Specimen Collection 2proxalutamide 1polyphenon E 1mirabegron 1Urination 1TroVax 1Transurethral Resection of Bladder 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Psychiatric Rehabilitation 1Prostate-Specific Antigen 1Papaverine 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Magnetic Resonance Spectroscopy 1Lycopene 1Levofloxacin 1Finasteride 1Electroacupuncture 1Doxazosin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Hyperplasia × Lycopene × Clear all
NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

National Cancer Institute (NCI)

Phase NA Completed
120 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡